Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Open accessAbstract
High-density lipoprotein (HDL) cholesterol (HDL-C) levels are a strong inverse predictor of atherosclerosis risk, but the physiological determinants of HDL-C levels are poorly understood. We selected 57 human subjects (30 women and 27 men) with a broad range of HDL-C levels and performed turnover studies of apolipoprotein (apo)A-I and apoA-II, the two major apolipoproteins of HDL, to measure the fractional catabolic rate (FCR) and production or transport rate (TR) of these proteins. We also measured several other parameters known to correlate with HDL-C levels to test for their interrelations and to postulate mechanisms of regulation of HDL-C levels. As expected, the women had higher levels of HDL-C (56.7 +/- 21.4 versus 45.1 +/- 16.3 mg/dL, mean +/- SD; P = .03) and apoA-I (147 +/- 32 versus 126 +/- 29 mg/dL, P = .01) than men and did not differ in apoA-II levels (34.5 +/- 7.4 versus 33.3 +/- 7.5 mg/dL, P > .2). The FCR of apoA-I tended to be lower in the women (0.248 +/- 0.077 versus 0.277 +/- 0.069 pools/d, P = .1), although the difference was not statistically significant. The FCR of apoA-II was also lower (0.184 +/- 0.043 versus 0.216 +/- 0.056 pools/d, P = .02). In contrast, the apoA-I TR was equal in women and men (12.0 +/- 1.6 versus 12.1 +/- 2.8 mg/kg per day, P > .2), and there was a trend toward lower apoA-II TR in women (2.19 +/- .62 versus 2.61 +/- 1.06 mg/kg per day, P = .07). Linear regression analysis revealed a strong inverse correlation between HDL-C levels and the FCRs of apoA-I and apoA-II (r = -.81 and -.76, respectively; P < .0001 for both). In contrast, there was little or no association between HDL-C and the TRs of apoA-I and apoA-II (r = .06 and -.35, P = not significant and .01, respectively). In stepwise multiple linear regression analysis, apoA-I FCR alone accounted for 66% of the variability in HDL-C; two other variables accounted for an additional 7%. Due to the importance of apoA-I FCR, its determinants were sought among the remaining variables.(ABSTRACT TRUNCATED AT 400 WORDS)
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I and seems related to elevated hepatic lipase activity in central obesity and insulin resistance.
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [48]
The Discussion links HDL size to hepatic lipase activity and suggests that abdominal fat may influence that activity. The Results report a positive association between abdominal fat distribution and hepatic lipase, but no significant association between fasting insulin and hepatic lipase. Thus, the central-obesity link is supported, while elevated hepatic lipase in insulin resistance is not established by this paper. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredCatabolism rather than production is the major determinant of HDL apoA-I levels.
“These data suggest that catabolism rather than production is the major determinant of HDL apoA-I levels, as suggested by previous studies (43)(44)(45).”
From Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans (2003) · cites this paper as [45]
The Discussion (page not available in our copy) says apoA-I fractional catabolic rate predicts variation in HDL cholesterol better than apoA-I production or transport rate. The claim instead concerns apoA-I levels; the same section notes a study suggesting that production rate may predict those levels better than catabolic rate. This paper therefore supports the comparison for HDL cholesterol, but not for the stated outcome. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621 · see citing works
A biometric study of basal metabolism in man
Harris, J. A., & Benedict, F. G. (2014) · Medical Entomology and Zoology · Cited by 1,847 · see citing works
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248 · see citing works
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212 · see citing works
Self-citationThe Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine and Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 831 · see citing works
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381 · see citing works
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337 · see citing works
Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.
Sadur, C. N., & Eckel, R. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110547 · Cited by 288 · see citing works
Grundy, S. M., Mok, H. Y. I., Zech, L. A., Steinberg, D. H., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283 · see citing works
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 258 · see citing works
Self-citationBrinton, E. A., Eisenberg, S., & Breslow, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115028 · Cited by 255 · see citing works
Self-citationHorowitz, B. S., Goldberg, I. J., Merab, J., Vanni, T. M., Ramakrishnan, R., & Ginsberg, H. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116384 · Cited by 231 · see citing works
Human Apolipoprotein A-I and A-II Metabolism
Brewer, H. B., Gregg, R. E., Law, S. W. T., Hoeg, J. M., & Zech, L. A. (1987) · Proceedings in life sciences · doi:10.1007/978-3-642-71702-4_44 · Cited by 218 · see citing works
In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
Dl, R., Castro, G., Zech, L. A., Fruchart, J., & Brewer, H. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41639-6 · Cited by 176 · see citing works
Haffner, S. M., Kushwaha, R. S., Foster, D. M., Applebaum-Bowden, D. M., & Hazzard, W. R. (1983) · Metabolism · doi:10.1016/0026-0495(83)90052-5 · Cited by 154 · see citing works
Golay, A., Zech, L. A., SHI, M.-Z., Chiou, Y.-A. M., Reaven, G. M., & Chen, Y. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-512 · Cited by 154 · see citing works
Fidge, N., Nestel, P. J., Ishikawa, T., Reardon, M., & Billington, T. (1980) · Metabolism · doi:10.1016/0026-0495(80)90109-2 · Cited by 140 · see citing works
Kuusi, T., Ehnholm, C., Viikari, J. S. A., Härkönen, R., Vartiainen, E. A., Puska, P., & Taskinen, M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38270-5 · Cited by 130 · see citing works
MAGILL, P., Rao, S. N., Miller, N. E., Nicoll, A., Brunzell, J., Hilaire, J., & Lewis, B. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00947.x · Cited by 122 · see citing works
Cheung, M., & Albers, J. J. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40631-5 · Cited by 114 · see citing works
Central adipose distribution is related to coronary atherosclerosis.
Thompson, C. J., Ryu, J. E., Craven, T. E., Kahl, F. R., & Crouse, J. R. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.327 · Cited by 88 · see citing works
Le, N., & Ginsberg, H. N. (1988) · Metabolism · doi:10.1016/0026-0495(88)90077-7 · Cited by 71 · see citing works
Gylling, H., Vega, G., & Grundy, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41407-5 · Cited by 67 · see citing works
Metabolism of human apolipoproteins A-I and A-II: compartmental models
Zech, L. A., Schaefer, E. J., Bronzert, T. J., AAMODT, R. L., & Brewer, H. B. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38025-1 · Cited by 67 · see citing works
A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II.
Shepherd, J., Packard, C. J., Gotto, A. M., & Taunton, O. D. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41299-4 · Cited by 66 · see citing works
Kagan, A. (1975) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(75)80032-8 · Cited by 65 · see citing works
Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., & Taunton, O. D. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00823.x · Cited by 57 · see citing works
Saku, K., Gartside, P. S., Hynd, B. A., Mendoza, S. G., & Kashyap, M. L. (1985) · Metabolism · doi:10.1016/0026-0495(85)90027-7 · Cited by 55 · see citing works
Rao, S. N., Magill, P. J., Miller, N. E., & Lewis, B. (1980) · Clinical Science · doi:10.1042/cs0590359 · Cited by 48 · see citing works
Accuracy of predictions of long-term energy needs
Mahalko, J. R., & Johnson, L. K. (1980) · Journal of the American Dietetic Association · doi:10.1016/s1094-7159(21)03566-2 · Cited by 34 · see citing works
Evaluation of a method for study of kinetics of autologous apolipoprotein A-I
Vega, G., Gylling, H., Nichols, A., & Grundy, S. M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42038-3 · Cited by 30 · see citing works
Malmendier, C. L., Delcroix, C., & Ameryckx, J. P. (1983) · Clinica Chimica Acta · doi:10.1016/0009-8981(83)90089-x · Cited by 29 · see citing works
High density lipoprotein turnover in patients with hypertension.
Chen, Y. I., Sheu, W. H., Swislocki, A., & Reaven, G. M. (1991) · Hypertension · doi:10.1161/01.hyp.17.3.386 · Cited by 24 · see citing works
High-density apolipoprotein A-I and A-II kinetics in relation to regional adiposity
Terry, R. B., Yurgalevitch, S. M., & Thompson, P. D. (1992) · Metabolism · doi:10.1016/0026-0495(92)90113-o · Cited by 13 · see citing works
Radio-immuno-assay of insulin.
Cr, P., Nc, P., & Bb, T. (1973) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Miller NE. High density lipoprotein as a predictor of clinical coronary heart disease. In: Fidge NH, Nestel PJ, eds. Athero- sclerosis VII. Amsterdam, the Netherlands: Elsevier; 1986:61.
- National Health and Nutrition Examination Survey. Dietary intake source data, 11. Hyattsville, Md: National Center for Health Statistics; Office of Health Research Statistics and Technology; 1983:48-52.
- Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipo- protein lipase. J Clin Invest. 1982;69:1119-1125.
Cited by
Sorted by citations
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,087 · see citing works
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
InfluentialAndrogens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592 · see citing works
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
Carlson, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 586 · see citing works
The metabolic syndrome: is this diagnosis necessary?
Reaven, G. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 546 · see citing works
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 511 · see citing works
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492 · see citing works
Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 419 · see citing works
Silva, E. R. D. O. E., Foster, D., Harper, M. M., Seidman, C. E., Smith, J. D., Breslow, J. L., & Brinton, E. A. (2000) · Circulation · doi:10.1161/01.cir.102.19.2347 · Cited by 321 · see citing works
Self-citationGlycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J. H., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310 · see citing works
Weinstock, P. H., Bisgaier, C. L., Aalto‐Setälä, K., Radner, H., Ramakrishnan, R., Levak‐Frank, S., Essenburg, A. D., Zechner, R., & Breslow, J. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118319 · Cited by 299 · see citing works
Self-citationTargeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287 · see citing works
Attie, A., Kastelein, J. J. P., & Hayden, M. R. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31498-x · Cited by 284 · see citing works
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277 · see citing works
Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review
Bjornstad, P., & Eckel, R. H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1101-6 · Cited by 245 · see citing works
Vaisman, B. L., Lambert, G. C., Amar, M. J., Joyce, C. W., Ito, T., Shamburek, R. D., Cain, W. J., Fruchart‐Najib, J., Neufeld, E. D., Remaley, A. T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12517 · Cited by 240 · see citing works
Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome
Gallagher, E. J., LeRoith, D., & Karnieli, E. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20212 · Cited by 236 · see citing works
Insulin resistance and coronary heart disease in nondiabetic individuals
Reaven, G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241885 · Cited by 227 · see citing works
Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., Wolfe, M. L., Rudling, M. J., Björkhem, I., Angelin, B., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161928.16334.dd · Cited by 229 · see citing works
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230 · see citing works
Gotto, A. M., & Brinton, E. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.061 · Cited by 228 · see citing works
Self-citationHow Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Welty, F. K. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0400-4 · Cited by 221 · see citing works
Watts, G. F., Barrett, P. H. R., Ji, J., Serone, A. P., Chan, D. C., Croft, K. D., Loehrer, F., & Johnson, A. G. (2003) · Diabetes · doi:10.2337/diabetes.52.3.803 · Cited by 219 · see citing works
Pascot, A., Lemieux, I., Prud’homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B., & Després, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31529-7 · Cited by 184 · see citing works
HDL metabolism in hypertriglyceridemic states: an overview
Lamarche, B., Rashid, S., & Lewis, G. F. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00098-4 · Cited by 184 · see citing works
Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels
Marcovina, S. M., & Packard, C. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01648.x · Cited by 180 · see citing works
Liadaki, K. N., Liu, T., Xu, S., Ishida, B. Y., Duchateaux, P. N., Krieger, J. P., Kane, J. P., Krieger, M., & Zannis, V. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002310200 · Cited by 162 · see citing works
Mekki, N., Christofilis, M., Charbonnier, M., Atlan-Gepner, C., Defoort, C., Juhel, C., Borel, P., Portugal, H., Pauli, A.-M., Vialettes, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5397 · Cited by 157 · see citing works
Faergeman, O., Holme, I., Fayyad, R., Bhatia, S., Grundy, S. M., Kastelein, J. J. P., LaRosa, J. C., Larsen, M. L., Lindahl, C., Olsson, A. G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.008 · Cited by 154 · see citing works
Hoehner, C. M., Greenlund, K. J., Rith-Najarian, S., Casper, M. L., & McClellan, W. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015762.92814.85 · Cited by 150 · see citing works
The insulin resistance syndrome and postprandial lipid intolerance in smokers
Eliasson, B., Mero, N., Taskinen, M., & Smith, U. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06028-5 · Cited by 149 · see citing works
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Tailleux, A., Duriez, P., Fruchart, J., & Barthelemy-Clavey, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00751-1 · Cited by 148 · see citing works
Weng, W., & Breslow, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14788 · Cited by 148 · see citing works
Self-citationBülow, B., Hagmar, L., ESKILSSON, J., & Erfurth, E. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6346 · Cited by 144 · see citing works
The impact of aerobic exercise on HDL quantity and quality: a narrative review
Franczyk, B., Gluba-Brzózka, A., Ciałkowska-Rysz, A., Ławiński, J., & Rysz, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054653 · Cited by 142 · see citing works
Reaven, G. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.12.001 · Cited by 138 · see citing works
Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132 · see citing works
Jeong, T., Schissel, S. L., Tabas, I. A., Pownall, H. J., Tall, A. R., & Jiang, X. (1998) · Journal of Clinical Investigation · doi:10.1172/jci870 · Cited by 133 · see citing works
GENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128 · see citing works
Self-citationTietge, U. J. F., Maugeais, C., Lund‐Katz, S., Grass, D., deBeer, F. C., & Rader, D. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023228.90866.29 · Cited by 126 · see citing works
Silver, D. L., Jiang, X., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4140 · Cited by 125 · see citing works
Brinton, E. A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.431 · Cited by 125 · see citing works
Self-citationHoeg, J. M., Vaisman, B. L., Demosky, S. J., Meyn, S. M., Talley, G. D., Hoyt, R. F., Feldman, S. H., Bérard, A. M., Sakai, N., Wood, D. R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4396 · Cited by 116 · see citing works
Freeman, D. J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.001 · Cited by 114 · see citing works
High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences
Francis, G. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00181-x · Cited by 114 · see citing works
Silver, D. L., Wang, N., & Tall, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8087 · Cited by 112 · see citing works
Hepatic lipase and HDL metabolism
Thuren, T. Y. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00008 · Cited by 111 · see citing works
Qin, S., Kawano, K., Bruce, C., Lin, M., Bisgaier, C. L., Tall, A. R., & Jiang, X. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32061-7 · Cited by 110 · see citing works
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p900015 · Cited by 108 · see citing works
Watts, G. F., & Playford, D. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00170-1 · Cited by 107 · see citing works
Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
Blatter, M.-C., Moren, X., & James, R. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500281-jlr200 · Cited by 107 · see citing works
Adenovirus-mediated Rescue of Lipoprotein Lipase-deficient Mice
Bogner‐Strauß, J. G., Frank, S., Kratky, D., Hämmerle, G., Hrzenjak, A., Knipping, G., von Eckardstein, A., Kostner, G. M., & Zechner, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104430200 · Cited by 103 · see citing works
Magkos, F., Mohammed, B. S., & Mittendorfer, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.164 · Cited by 102 · see citing works
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M. R., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900015-jlr200 · Cited by 102 · see citing works
Plasma HDL Cholesterol, Triglycerides, and Adiposity
Mahaney, M. C., Blangero, J., Comuzzie, A. G., VandeBerg, J. L., D, M. P. S. M., & MacCluer, J. W. (1995) · Circulation · doi:10.1161/01.cir.92.11.3240 · Cited by 102 · see citing works
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states
Rashid, S., Uffelman, K. D., & Lewis, G. F. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00191-x · Cited by 101 · see citing works
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions
Siri, P. W., & Krauss, R. M. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0062-9 · Cited by 97 · see citing works
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.37 · Cited by 96 · see citing works
Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation
Rashid, S., Barrett, P. H. R., Uffelman, K. D., Watanabe, T., Adeli, K., & Lewis, G. F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105374 · Cited by 96 · see citing works
Associations of indices of adiposity with atherogenic lipoprotein subfractions
Sattar, N. A., Tan, C., Han, T. S., Forster, L. F., Lean, M., Shepherd, J., & Packard, C. J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800604 · Cited by 93 · see citing works
Freeman, Caslake, Griffin, Hinnie, Tan, �., Watson, Packard, & Shepherd (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00328.x · Cited by 89 · see citing works
Changes of lipolytic enzymes cluster with insulin resistance syndrome
Knudsen, P., Eriksson, J., Lahdenper, S., Kahri, J., Groop, L., Taskinen, M., & The Botnia Study Group (1995) · Diabetologia · doi:10.1007/bf00400640 · Cited by 87 · see citing works
Tan, K. C. B., Shiu, S. W. M., & Kung, A. W. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4938 · Cited by 85 · see citing works
Beard, C. M., Barnard, R. J., Robbins, D. C., Ordovás, J. M., & Schaefer, E. J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.201 · Cited by 81 · see citing works
Levak‐Frank, S., Weinstock, P. H., Hayek, T., Verdery, R. B., Hofmann, W. E., Ramakrishnan, R., Sattler, W., Breslow, J. L., & Zechner, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17182 · Cited by 81 · see citing works
Self-citationSmall, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
Blatter, M.-C., Kalix, B., Morabia, A., & James, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1295 · Cited by 79 · see citing works
Determinants of plasma HDL concentrations and reverse cholesterol transport
Lewis, G. F. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231405.76930.a0 · Cited by 77 · see citing works
Brousseau, M. E., Eberhart, G. P., Dupuis, J., Asztalos, B. F., Goldkamp, A. L., Schaefer, E. J., & Freeman, M. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32019-8 · Cited by 77 · see citing works
Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M
Wolfrum, C., Howell, J. J., Ndungo, E., & Stoffel, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801930200 · Cited by 74 · see citing works
Mendivil, C. O., Furtado, J. D., Morton, A. M., Wang, L., & Sacks, F. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306138 · Cited by 74 · see citing works
Asztalos, B. F., Collins, D., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.009 · Cited by 71 · see citing works
Impaired Serum Lipids and Lipoproteins in Fetal Macrosomia Related to Maternal Obesity
Merzouk, H., Bouchenak, M., Loukidi, B., Prost, J., & Belleville, J. (1999) · Neonatology · doi:10.1159/000014190 · Cited by 74 · see citing works
Arginine-directed glycation and decreased HDL plasma concentration and functionality
Godfrey, L., Yamada-Fowler, N., Smith, J., Thornalley, P. J., & Rabbani, N. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.31 · Cited by 73 · see citing works
Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients
Tatò, F., Vega, G. L., & Grundy, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.56 · Cited by 72 · see citing works
Chan, D. C., & Watts, G. F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.502529 · Cited by 69 · see citing works
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications
Remaley, A. T., Amar, M. J., & Sviridov, D. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.9.1203 · Cited by 69 · see citing works
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions.
Ganjali, S., Momtazi, A. A., Banach, M., Kovanen, P., Stein, E., & Sahebkar, A. (2017) · Progress in lipid research · doi:10.1016/j.plipres.2017.05.001 · Cited by 66 · see citing works
Yan, D., Navab, M., Bruce, C., Fogelman, A. M., & Jiang, X. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400053-jlr200 · Cited by 67 · see citing works
Tan, Shiu, Pang, & Kung (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00372.x · Cited by 65 · see citing works
Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs
Suzuki, H., Aoki, T., Tamaki, T., Sato, F., Kitahara, M., & Saitō, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00146-x · Cited by 65 · see citing works
HDL particle size: a marker of the gender difference in the metabolic risk profile.
Pascot, A., Lemieux, I., Bergeron, J., Tremblay, A., Nadeau, A., Prud'homme, D., Couillard, C., Lamarche, B., & Despres, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00579-2 · Cited by 65 · see citing works
Insulin Resistance and Human Disease: A Short History
Reaven, G. M. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.387 · Cited by 64 · see citing works
Simonsen, J. B. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.009 · Cited by 64 · see citing works
Azrolan, N., Odaka, H., Breslow, J. L., & Fisher, E. A. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19833 · Cited by 63 · see citing works
Self-citationHager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 61 · see citing works
Rodríguez‐Carrio, J., Alpéri, M., López, P., López‐Mejías, R., Alonso-Castro, S., Abal, F., Ballina‐García, F. J., González-Gay, M. Á., & Suárez, A. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.009 · Cited by 61 · see citing works
Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I
Batal, R., Tremblay, M., Krimbou, L., Mamer, O., Davignon, J., Genest, J. J., & Cohn, J. S. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.655 · Cited by 61 · see citing works
Silva, E. R. D. O. E., Kong, M., Han, Z., Starr, C. J., Kass, E. M., Juo, S. H., Foster, D., Dansky, H. M., Merkel, M., Cundey, K., et al. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33483-0 · Cited by 61 · see citing works
Self-citationWeng, W., Brandenburg, N. A., Zhong, S., Halkias, J., Wu, L., Jiang, X., Tall, A. R., & Breslow, J. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33510-0 · Cited by 61 · see citing works
Self-citationType 2 diabetes affects hippocampus volume differentially in men and women
Hempel, R., Onopa, R., & Convit, A. J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1230 · Cited by 60 · see citing works
Haas, M. J., & Mooradian, A. D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1057 · Cited by 60 · see citing works
Al-Shoumer, K. A. S., Cox, K. H., Hughes, C. L., Richmond, W., & Johnston, D. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4129 · Cited by 60 · see citing works
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects
Catalano, G., Duchêne, E., Julia, Z., Goff, W. L., Bruckert, É., Chapman, M. J., & Guérin, M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700510-jlr200 · Cited by 60 · see citing works
Tan, K. C. B., Shiu, S. W. M., Pang, R. W. C., & Kung, A. W. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3721211.x · Cited by 60 · see citing works
Mazer, N. A., Giulianini, F., Paynter, N. P., Jordan, P., & Mora, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196949 · Cited by 59 · see citing works
Duvillard, L., Pont, F., Florentin, E., Gambert, P., & Vergès, B. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00473-6 · Cited by 59 · see citing works
Murdoch, S. J., & Breckenridge, W. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05606-8 · Cited by 58 · see citing works
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei × C57BL/6J)
Mehrabian, M., Castellani, L. W., Wen, P.-Z., Wong, J., Rithaporn, T., Hama, S. Y., Hough, G. P., Johnson, D., Albers, J. J., Mottino, G. A., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32354-3 · Cited by 58 · see citing works
Tailleux, A., Bouly, M., Luc, G., Castro, G. R., Caillaud, J., Hennuyer, N., Poulain, P., Fruchart, J., Duverger, N., & Fiévet, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2453 · Cited by 58 · see citing works
Differential response to low-fat diet between low and normal HDL-cholesterol subjects
Asztalos, B. F., LeFevre, M. L., Wong, L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Zhang, W., & Roheim, P. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34470-9 · Cited by 57 · see citing works
- Authors
- Brinton, E. A., Eisenberg, S., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1994-05
- Volume
- 14
- Issue
- 5
- Pages
- 707-720
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2155588817
- Cited by
- 265
- References
- 36
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 3
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pew Charitable Trusts
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL-36461, HL32435)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- HDL cholesterol, apolipoprotein A-I, apolipoprotein A-II, fractional catabolic rate, HDL particle size, sex differences, hepatic lipase, lipoprotein lipase, triglycerides, insulin, body fat distribution, atherosclerosis risk
- MeSH terms
- Adipose Tissue, Adult, Aged, Female, Humans, Insulin, Lipase, Lipoprotein Lipase, Lipoproteins, HDL, Cholesterol, HDL, Liver, Male, Middle Aged, Particle Size, Regression Analysis, Sex Factors, Triglycerides, Apolipoprotein A-I, Apolipoprotein A-II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review